About Palobiofarma
Palobiofarma S.L is a Spanish biotechnology company founded in 2006 by a group of scientists with experience in drug discovery in several pharmaceutical companies.
Mission
The mission of the Palobiofarma is to discover new drugs based on the modulation of adenosine receptors
Vision
The Vision of Palobiofarma is to discover the first marketed drug based on a selective adenosine receptor modulator.
How do we achieve our vision
Palobiofarma focused internal resources on areas where lies the experience of the management team::
- Virtual drug design
- Medicinal Chemistry
- In Vitro Pharmacology of adenosine
- Physico-chemical characterization of the compounds
- Intellectual Property
The remaining activities needed for the full compound characterization and the nomination of a development candidate, such as the pharmacology and toxicology tests, are carried out through partnerships with various companies (CROs), Research Centres and Universities.